Evidence map›Paper›PMID 38147217›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization.

Sophie Rizzo, Damien Thévenin

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sophie RizzoDepartment of Chemistry, Lehigh University, Bethlehem, PA, USA.
Damien ThéveninDepartment of Chemistry, Lehigh University, Bethlehem, PA, USA. damien.thevenin@lehigh.edu.
Lehigh University · US

Funding

Promoting Receptor Protein Tyrosine Phosphatase Activity by TargetingTransmembrane Domain InteractionsR01GM139998 · NIGMS · LEHIGH UNIVERSITY · PI LAZZARA, MATTHEW J, THEVENIN, DAMIEN · 2020 to 2023
$1.7M
NIGMS NIH HHS R01 GM139998
6 · The paper itself

Abstract

Receptor protein tyrosine phosphatases (RPTPs) are one of the key regulators of receptor tyrosine kinases (RTKs) and therefore play a critical role in modulating signal transduction. While the structure-function relationship of RTKs has been widely studied, the mechanisms modulating the activity of RPTPs still need to be fully understood. On the other hand, homodimerization has been shown to antagonize RPTP catalytic activity and appears to be a general feature of the entire family. Conversely, their documented ability to physically interact with RTKs is integral to their negative regulation of RTKs, but there is a yet-to-be proposed common model. However, specific transmembrane (TM) domain interactions and residues have been shown to be essential in regulating RPTP homodimerization, interactions with RTK substrates, and activity. Therefore, elucidating the contribution of the TM domains in RPTP regulation can provide significant insights into how these receptors function, interact, and eventually be modulated. This chapter describes the dominant-negative AraC-based transcriptional reporter (DN-AraTM) assay to identify specific TM interactions essential to homodimerization and heteroassociation with other membrane receptors, such as RTKs.

Indexed as

Protein Tyrosine PhosphatasesSignal TransductionBiological AssayProtein DomainsReceptor Protein-Tyrosine KinasesProtein Tyrosine PhosphatasesReceptor Protein-Tyrosine KinasesBacterial transcription-based reporter assayDimerizationReceptor protein tyrosine kinaseReceptor protein tyrosine phosphataseTransmembrane domain interaction

Identifiers

PMID38147217
PMCPMC10785008
OpenAlexW4390235877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.